Pediatric Lupus
Low Childhood Opportunity Index score may drive inequitable outcomes in pediatric lupus
WASHINGTON — Children with lupus from areas of lower socioeconomic opportunity experience more severe disease complications and poorer outcomes than those from higher opportunity areas, according to data presented at ACR Convergence 2024.
Methylprednisolone exposure a significant risk factor for organ damage in pediatric lupus
Reducing steroids in favor of more targeted therapies can minimize organ damage in pediatric systemic lupus erythematosus, according to data presented at EULAR 2024 Congress.
Lupus Research Alliance grants $3 million award to study pediatric lupus nephritis
Nearly 25% of children with systemic lupus erythematosus develop growth impairment
Growth impairment was reported in 23.6% of children with systemic lupus erythematosus, with corticosteroid duration and exposure prior to late puberty identified as key risk factors, according to data published in Pediatric Rheumatology.
Mitochondrial abnormalities a prognostic marker for juvenile dermatomyositis
ATLANTA — Patients with juvenile dermatomyositis demonstrate obvious mitochondrial abnormalities in the tissue and periphery, supporting the use of anti-mitochondrial antibodies as a prognostic marker, according to data presented at ACR/ARP 2019.